Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity.
暂无分享，去创建一个
C. Voisset | F. Bihel | J. Bourguignon | S. Sanyal | M. Blondel | V. Béringue | M. Schmitt | H. Hammoud | Sophie Halliez | N. Oumata | P. Nguyen | Yanhong Pang | J. Evrard | Nassima Oumata | S. Halliez